Roche Hldg AG GEN

RHO5 
(XETRA) 
 
246.95 <%= Resources.Global.txtUp %>
Updated 13/06/2019
Change % 0.14% Stock price increasing
Change 0.35 Stock price increasing
Volume 6,956
High 247.00
Low 245.20
Open 246.25
ISIN CH0012032048
Prev close 246.60
# of shares 702.56M
Market cap 173,498M EUR
Intraday

Market closed
Roche Hldg AG GEN
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  246.95 2.1% Stock price increasing 5.7% Stock price increasing 3.0% Stock price increasing 11.5% Stock price increasing 37.3% Stock price increasing
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 82.22 1.8% Stock price increasing 7.3% Stock price increasing 3.0% Stock price increasing 16.2% Stock price increasing 30.7% Stock price increasing 13.7% Stock price increasing
 
Bristol-Myers Squibb Company 47.56 1.7% Stock price increasing 0.9% Stock price increasing -4.8% Stock price decreasing -8.7% Stock price decreasing -13.2% Stock price decreasing -8.5% Stock price decreasing
 
Eli Lilly and Company 111.74 -5.6% Stock price decreasing -4.3% Stock price decreasing -9.8% Stock price decreasing -0.2% Stock price decreasing 28.6% Stock price increasing -3.4% Stock price decreasing
 
Merck & Company Inc (new) 82.78 0.4% Stock price increasing 4.6% Stock price increasing 1.5% Stock price increasing 8.2% Stock price increasing 33.5% Stock price increasing 8.3% Stock price increasing
 
Pfizer Inc 42.76 -0.4% Stock price decreasing 2.7% Stock price increasing 2.3% Stock price increasing -2.4% Stock price decreasing 17.6% Stock price increasing -2.0% Stock price decreasing
 
Astrazeneca PLC ORD SHS $0.25 6,215.00 3.1% Stock price increasing 5.7% Stock price increasing -0.9% Stock price decreasing 1.4% Stock price increasing 15.1% Stock price increasing 5.8% Stock price increasing
 
Novartis NAM SF 0,50 79.74 2.1% Stock price increasing 7.5% Stock price increasing -3.3% Stock price decreasing 2.8% Stock price increasing 22.1% Stock price increasing 7.2% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1,584.40 1.2% Stock price increasing 2.2% Stock price increasing 5.5% Stock price increasing 7.1% Stock price increasing 1.8% Stock price increasing 6.3% Stock price increasing
 
Sanofi 75.98 -3.0% Stock price decreasing 1.3% Stock price increasing -4.5% Stock price decreasing -2.9% Stock price decreasing 10.6% Stock price increasing 0.4% Stock price increasing

Company profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 60% of pharmaceutical sales, and professional diagnostics for more than half of diagnostic-related sales.

Peers

Instruments Last Change  
Abbott Labor.. 82.22 -0.1% Stock price decreasing
Bristol-Myer.. 47.56 0.5% Stock price increasing
Eli Lilly an.. 111.74 -0.1% Stock price decreasing
Merck & Comp.. 82.78 0.5% Stock price increasing
Pfizer Inc 42.76 0.6% Stock price increasing
Astrazeneca .. 6,215.00 0.3% Stock price increasing
Novartis NAM.. 79.74 0.6% Stock price increasing
Glaxosmithkl.. 1,584.40 0.1% Stock price increasing
Sanofi 75.98 0.0% Stock price unchanged

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
16 June 2019 18:33:45
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB2 - 2019-06-16 19:33:45 - 2019-06-16 18:33:45 - 1000 - Website: OKAY